.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Novartis
Teva
Julphar
Daiichi Sankyo
Cipla
Accenture
Queensland Health
Cerilliant

Generated: June 22, 2017

DrugPatentWatch Database Preview

BREATHTEK UBT FOR H-PYLORI Drug Profile

« Back to Dashboard

What is the patent landscape for Breathtek Ubt For H-pylori, and when can generic versions of Breathtek Ubt For H-pylori launch?

Breathtek Ubt For H-pylori is a drug marketed by Otsuka America and is included in one NDA.

The generic ingredient in BREATHTEK UBT FOR H-PYLORI is urea c-13. There are thirty-two drug master file entries for this compound. Additional details are available on the urea c-13 profile page.

Summary for Tradename: BREATHTEK UBT FOR H-PYLORI

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list94
Clinical Trials: see list234
Patent Applications: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BREATHTEK UBT FOR H-PYLORI at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka America
BREATHTEK UBT FOR H-PYLORI
urea c-13
FOR SOLUTION;ORAL020586-002May 10, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BREATHTEK UBT FOR H-PYLORI

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Otsuka America
BREATHTEK UBT FOR H-PYLORI
urea c-13
FOR SOLUTION;ORAL020586-002May 10, 20014,830,010► Subscribe
Otsuka America
BREATHTEK UBT FOR H-PYLORI
urea c-13
FOR SOLUTION;ORAL020586-002May 10, 20015,140,993► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKinsey
Healthtrust
Citi
Teva
Merck
Farmers Insurance
Julphar
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot